Mid-Illinois Hematology Oncology Associates Limited — Normal, Illinois

Mid-Illinois Hematology Oncology Associates Limited is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid-Illinois Hematology Oncology Associates Limited has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma.

Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Normal

Browse all research sites in Illinois · View every site in Normal

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Illinois Hematology Oncology Associates Limited?

Mid-Illinois Hematology Oncology Associates Limited has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Illinois Hematology Oncology Associates Limited conducted?

Mid-Illinois Hematology Oncology Associates Limited has 7 clinical trials on record, with 4 currently active. Their work covers Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma.

Is Mid-Illinois Hematology Oncology Associates Limited accredited by Crixeo Clinical Trials?

Mid-Illinois Hematology Oncology Associates Limited has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Illinois Hematology Oncology Associates Limited?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.